Individual Tumor Profiling
Has Tumor Molecular Profiling Enabled More Effective and Less Toxic Cancer Treatment?
Top 10 Under 40
Up-and-Coming Stars Shine in Biopharma Research and Business
Podcast: FDA’s New Commissioner Hits the Ground Running
Scott Gottlieb, M.D., Commits to Speeding Up Drug Reviews, and Maintaining Safety and Efficacy
Liquid Biopsies Remain Wait and See for Some Clinicians
Circulating Biomarker Assays Promise to Refresh Cancer Profiling and Monitoring Practices
- Cambridge Epigenetix
- Citibase Cambridge, Sheraton House
- Castle Park
- Cambridge , CB3 0AX
- UNITED KINGDOM
Cambridge Epigenetix is a biosciences company developing epigenetics research tools. It aims to develop technologies that have a significant impact on next-generation sequencing systems, methylation arrays, and targeted assays resulting in new avenues for research, pharmaceutical discovery, and diagnostics.